In ₹ Crore except Per Share 12 Months Ending | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|
| Revenue from Operations | 8.2 | 0.0 | 0.1 | 0.2 | |
| Other Income | 0.3 | 0.0 | 0.0 | 0.0 | |
| Total Income | 8.5 | 0.0 | 0.1 | 0.2 | |
| Expenses | |||||
| + Purchases of Stock-in-Trade | 6.9 | 0.0 | 0.0 | 0.2 | |
| + Changes in Inventories | 8.7 | 0.0 | 0.1 | -0.0 | |
| + Employee Benefit Expense | 0.2 | 0.1 | 0.1 | 0.1 | |
| + Finance Costs | 0.7 | 0.5 | 0.4 | 0.4 | |
| + Depreciation & Amortisation | 0.7 | 0.6 | 0.5 | 0.5 | |
| + Other Expenses | 6.9 | 0.6 | 0.6 | 0.5 | |
| Total Expenses | 24.0 | 1.8 | 1.7 | 1.7 | |
| EBITDA | -14.5 | -0.7 | -0.7 | -0.5 | |
| EBIT | -15.2 | -1.3 | -1.2 | -1.0 | |
| Profit | |||||
| PBT before Exceptional Items | -15.5 | -1.8 | -1.6 | -1.4 | |
| Pretax Income | -15.5 | -1.8 | -1.6 | -1.4 | |
| + Deferred Tax | 0.0 | -0.1 | -0.1 | -0.1 | |
| Tax Expense | 0.0 | -0.1 | -0.1 | -0.1 | |
| Net Income | -15.5 | -1.7 | -1.5 | -1.3 | |
| + Net Income — Continuing Ops | -15.5 | -1.7 | -1.5 | -1.3 | |
| Total Comprehensive Income | -15.5 | -1.7 | -1.5 | -1.3 | |
| Per Share | |||||
| Basic EPS | -0.53 | -0.12 | -0.05 | -0.05 | |
| Diluted EPS | -0.53 | -0.12 | -0.05 | -0.05 | |
| Per Share — as-filed variants | |||||
| Basic EPS — Continuing Operations | -0.53 | -0.06 | -0.05 | -0.04 | |
| Diluted EPS — Continuing Operations | -0.53 | -0.06 | -0.05 | -0.04 | |
| Basic EPS — Discontinued Operations | 0.00 | -0.06 | 0.00 | -0.01 | |
| Diluted EPS — Discontinued Operations | 0.00 | -0.06 | 0.00 | -0.01 | |
| Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories) | |||||
| Gross Profit | -7.4 | 0.0 | 0.0 | 0.1 | |
| Gross Margin % | -90.44 | — | 24.22 | 23.55 | |
| Adjusted (ex-Exceptional Items) — derived | |||||
| Pretax Income (Adjusted, as filed) | -15.5 | -1.8 | -1.6 | -1.4 | |
| Net Income Adj (tax-effected) | -15.5 | -1.7 | -1.5 | -1.3 | |
| EPS Adj | -0.53 | -0.12 | -0.05 | -0.05 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | |||||
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | |
| Paid Up Equity Capital | 29.3 | 29.3 | 29.3 | 29.3 | |